Arecor Therapeutics plc

AIM:AREC Stock Report

Market Cap: UK£28.7m

Arecor Therapeutics Management

Management criteria checks 2/4

Arecor Therapeutics' CEO is Sarah Howell, appointed in Jun 2015, has a tenure of 9.42 years. total yearly compensation is £439.00K, comprised of 59.2% salary and 40.8% bonuses, including company stock and options. directly owns 2.3% of the company’s shares, worth £663.82K. The average tenure of the management team and the board of directors is 5.5 years and 7.2 years respectively.

Key information

Sarah Howell

Chief executive officer

UK£439.0k

Total compensation

CEO salary percentage59.2%
CEO tenure9.4yrs
CEO ownership2.3%
Management average tenure5.5yrs
Board average tenure7.2yrs

Recent management updates

Recent updates

Companies Like Arecor Therapeutics (LON:AREC) Are In A Position To Invest In Growth

Jul 16
Companies Like Arecor Therapeutics (LON:AREC) Are In A Position To Invest In Growth

Will Arecor Therapeutics (LON:AREC) Spend Its Cash Wisely?

Mar 15
Will Arecor Therapeutics (LON:AREC) Spend Its Cash Wisely?

CEO Compensation Analysis

How has Sarah Howell's remuneration changed compared to Arecor Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-UK£9m

Mar 31 2024n/an/a

-UK£9m

Dec 31 2023UK£439kUK£260k

-UK£9m

Sep 30 2023n/an/a

-UK£9m

Jun 30 2023n/an/a

-UK£9m

Mar 31 2023n/an/a

-UK£9m

Dec 31 2022UK£421kUK£250k

-UK£9m

Sep 30 2022n/an/a

-UK£8m

Jun 30 2022n/an/a

-UK£7m

Mar 31 2022n/an/a

-UK£7m

Dec 31 2021UK£343kUK£218k

-UK£6m

Compensation vs Market: Sarah's total compensation ($USD553.43K) is above average for companies of similar size in the UK market ($USD355.82K).

Compensation vs Earnings: Sarah's compensation has increased whilst the company is unprofitable.


CEO

Sarah Howell (49 yo)

9.4yrs

Tenure

UK£439,000

Compensation

Dr. Sarah Jennifer Howell, Ph.D. has been the Chief Executive Officer of Arecor Therapeutics PLC since June 2015. Having joined in 2011 as Chief Operating Officer and Executive Director. During her time at...


Leadership Team

NamePositionTenureCompensationOwnership
Sarah Howell
CEO & Director9.4yrsUK£439.00k2.3%
£ 659.5k
Jan Jezek
Chief Scientific Officer17.8yrsno datano data
David Gerring
Senior Vice President of Development1.3yrsno datano data
Manjit Rahelu
Chief Business Officer1.6yrsno datano data

5.5yrs

Average Tenure

Experienced Management: AREC's management team is seasoned and experienced (5.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Sarah Howell
CEO & Director3.6yrsUK£439.00k2.3%
£ 659.5k
Christine Soden
Independent Non-Executive Director3.5yrsUK£40.00k0.051%
£ 14.6k
Alan Smith
Non-Executive Directorno dataUK£35.00k0.48%
£ 138.1k
Andrew John Richards
Non-Executive Chairman8.2yrsUK£80.00k0.59%
£ 170.1k
Mohammad Fazeli
Independent Non-Executive Director7.2yrsUK£35.00k0.31%
£ 87.9k
Bruce Buckingham
Member of Global Diabetes Scientific Advisory Board7.2yrsno datano data
Eda Cengiz
Member of Global Diabetes Scientific Advisory Board7.2yrsno datano data
Thomas Pieber
Member of Global Diabetes Scientific Advisory Board7.2yrsno datano data
Jeremy Lewis Morgan
Independent Non-Executive Director3.5yrsUK£40.00k0.072%
£ 20.6k

7.2yrs

Average Tenure

62.5yo

Average Age

Experienced Board: AREC's board of directors are considered experienced (7.2 years average tenure).